Venter Pharma And NovaMedica Sign Agreement To Commercialize New Lactose Intolerance Test In Russia

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MADRID & MOSCOW--(BUSINESS WIRE)--NovaMedica LLC, a Russian pharmaceutical company, and Venter Pharma SL, a Spanish company, developing innovative diagnostic systems, have signed a partnership agreement that grants NovaMedica exclusive rights to commercialize a new technology for the diagnosis of lactose intolerance, LacTEST®, in Russia and the Community of Independent States (CIS).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC